Pieris Pharmaceuticals Inc
NASDAQ:PVLA
Pieris Pharmaceuticals Inc
NASDAQ:PVLA
Price:
116.26
USD
-1.13%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pieris Pharmaceuticals Inc
NASDAQ:PVLA
|
US |
|
A2A SpA
OTC:AEMMF
|
IT |
|
E
|
Endesa SA
XHAM:ENA
|
ES |
|
C
|
CSW Industrials Inc
F:UCI
|
US |
|
Vivoryon Therapeutics NV
LSE:0R3M
|
DE |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
S
|
Sun Life Financial Inc
F:LIE
|
CA |
|
P
|
Power Corporation of Canada
OTC:PWCDF
|
CA |
|
C
|
China Literature Ltd
F:C2X
|
CN |
|
B
|
Bank of Communications Co Ltd
SWB:C4C
|
CN |
Wall St Price Targets
PVLA Price Targets Summary
Pieris Pharmaceuticals Inc
Pieris Pharmaceuticals Inc
Wall Street analysts forecast PVLA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PVLA is 233.04 USD with a low forecast of 207.05 USD and a high forecast of 283.5 USD.
Lowest Forecast
Price Target
207.05
USD
78% Upside
Average Forecast
Price Target
233.04
USD
100% Upside
Highest Forecast
Price Target
283.5
USD
144% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PVLA's stock price target?
Price Target
233.04
USD
233.04
USD
According to Wall Street analysts, the average 1-year price target for PVLA is 233.04 USD with a low forecast of 207.05 USD and a high forecast of 283.5 USD.
